[Improving the anti-tumor activity of 5-fluorouracil by methotrexate].

Konishi, T; Noie, T; Abe, T; Agawa, S; Furushima, K; Ito, K; Mafune, K; Makuuchi, M; Teruya, M; Nouchi, T

Konishi, T; Noie, T; Abe, T; Agawa, S; Furushima, K; Ito, K; Mafune, K; Makuuchi, M; Teruya, M; Nouchi, T.

Affiliation

Konishi T; Department of Surgery, Kanto Teishin Hospital, Tokyo, Japan.

Gan To Kagaku Ryoho ; 26(4): 431-9, 1999 Mar.

Article in Ja | MEDLINE | ID: mdl-10097739

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/pharmacology; Fluorouracil/pharmacology; Methotrexate/pharmacology; Stomach Neoplasms/drug therapy; Animals; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; DNA/biosynthesis; Drug Administration Schedule; Drug Synergism; Fluorouracil/administration & dosage; Humans; Methotrexate/administration & dosage; Stomach Neoplasms/chemistry

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Stomach Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Methotrexate / Fluorouracil Language: Ja Journal: Gan To Kagaku Ryoho Year: 1999 Type: Article Affiliation country: Japan

Search on Google

Add to My VHL

XML

PubMed Links